In-Vitro Diagnostics, Point of Care Testing & Pathology Services Project_1717

What the buyer is asking for

NHS Supply Chain intends to launch a National Framework Agreement for the provision of In-Vitro Diagnostic Devices, Point of Care Testing Products & Related Pathology Services, this will include: - Pathology Managed Services - Reagent Rental Agreements - Pathology Software - Core Laboratory Equipment, Instruments & Consumables, to cover all pathology disciplines such as but not limited to Biochemistry, Microbiology, Immunology, Cellular Pathology, Virology, Haematology, Genomics & Molecular Testing and Reproductive Sciences - Point of Care Testing - Specimen Collection - Specimen Storage

How this is scored

Published by the buyer. A winning response is written to these weightings, not to the question.

• 10%qualityTechnical Envelope - Social Value
• 80%qualityTechnical Envelope – Non-Financial
• 10%priceCommercial Envelope

3 lots

You can usually bid for one lot without bidding for all of them.

• Pathology Managed Services£703m

  This Lot seeks Managed Service (MS) solutions that delivers end-to-end pathology and POCT outcomes (preanalytical > analytical > postanalytical) with assured quality, resilient capacity, and measurable operational/clinical impact, while enabling the expansion of diagnostics into Community Diagnostic Centres (CDCs) and neighbourhood/community settings consistent with the NHS 10 Year Plan’s shift hospital > community; analogue > digital; sickness > prevention.

• Pathology Software Solutions£703m

  This Lot seeks to enable the procurement of IT Solutions that include but are not limited to Software, Middleware, Artificial Intelligence (AI) platforms, that will offer support in: • Clinical laboratory workflows • Diagnostic processing & Reporting • Sample Tracking & Archiving Solutions • Data interoperability across systems • Long term sample archiving • Specimen analysis and management • Integration with laboratory hardware • Modernisation & Transformation solutions • Laboratory Monitoring Solutions

• Diagnostics Testing Solutions£703m

  This Lot seeks solutions that deliver safe, reliable, efficient and interoperable diagnostic outcomes across all pathology disciplines, NHS Screening Programmes and diagnostic care settings. Solutions may support the delivery of diagnostic services within laboratory environments, point of care settings, community diagnostic services and home/self-testing pathways whilst maintaining appropriate clinical performance, quality assurance, governance, interoperability and patient safety requirements. Solutions offered may support including but not limited to: • Blood Sciences (Haematology, Coagulation, Clinical Chemistry, Immunoassay, Toxicology, Transfusion & Transplantation Support) • Cellular Pathology (Histology, Cytology, Immunohistochemistry, In Situ Hybridisation) • Microbiology, Virology & Serology • Transfusion & Transplantation Support • Genomics & Molecular Diagnostics • Digital Pat

How contested is this?

Buyers publish how many bids they received. Across 107 comparable procurements we can tell you the typical field size, how often one of these goes uncontested, and whether the buyer awards on price or on quality.

Timeline

4 published dates · Europe/London

1. Tender notice published9 days ago

   28 Oct 2026, 11:42 GMT
2. Clarification questions byin 34 days

   10 Dec 2026, 15:00 GMT
3. Submission deadlinein 40 days

   16 Dec 2026, 15:00 GMT
4. Award decision expected byin 268 days

   1 Aug 2027, 23:59 BST

Commercial outcome and contract awards

Nothing awarded yet

Notice history

5 events · 5 releases on Find a Tender

1. Pipeline or early engagement notice13 Mar 2026, 16:35 GMT023200-2026
2. Pipeline or early engagement notice14 Apr 2026, 14:16 BST033793-2026
3. Notice published15 Apr 2026, 13:35 BST034208-2026
4. Tender notice22 Oct 2026, 19:15 BST100209-2026
5. Tender updated28 Oct 2026, 11:42 GMT101987-2026

Documents

• Tender notice on Find a Tender